MedPath
FDA Approval

Exemestane

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
June 19, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Exemestane(25 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Qilu Pharmaceutical Co., Ltd. (Biological Industrial Park)

Florida Pharmaceutical Products, LLC

544532200

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Exemestane

Product Details

NDC Product Code
71921-190
Application Number
ANDA213547
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
June 19, 2023
MANNITOLInactive
Code: 3OWL53L36AClass: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8HClass: IACT
HYPROMELLOSE 2910 (5 MPA.S)Inactive
Code: R75537T0T4Class: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POLYETHYLENE GLYCOL 3350Inactive
Code: G2M7P15E5PClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
POLYVINYL ALCOHOL, UNSPECIFIEDInactive
Code: 532B59J990Class: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
Code: NY22HMQ4BXClass: ACTIBQuantity: 25 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath